Recombinant fusion protein containing a sequence corresponding to amino acids 411 - 610 of human ENOX2.
Conjugate
Unconjugated
Applications
Application Notes
WB: 1:1000-1:5000 ELISA: Recommended starting concentration is 1 μg/mL
General Notes
This product (Catalog No. CABT-L1600W) is a rabbit-derived monoclonal antibody raised against human ENOX2, targeting the amino acid region 411–610 of the protein. This antibody exhibits cross-reactivity with Human ENOX2 from rat. It has been affinity purified by Protein A. Tumor-associated NADH oxidase (ENOX2) as a member of a family of growth-related NADH (or hydroquinone) oxidases. It functions as a terminal oxidase of plasma electron transport from cytosolic NAD(P)H via hydroquinones to acceptors at the cell surface. Hydroquinone oxidase activity alternates with a protein disulfide-thiol interchange/oxidoreductase activity which may control physical membrane displacements associated with vesicle budding or cell enlargement. The activities oscillate with a period length of 22 minutes and play a role in control of the ultradian cellular biological clock. CABT-L1600W is suitable for use in Western blot (WB) (1:1,000–1:5,000), ELISA (Recommended starting concentration is 1 μg/mL) applications. CABT-L1600W is supplied as a liquid formulation in PBS with 50% glycerol, 0.05% BSA, and 0.05% proclin300. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
My Review for Rabbit Anti-Human ENOX2 (a.a. 411-610) Monoclonal antibody, clone 12
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.